A PHASE I STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF ORALLY ADMINISTERED APG-2575 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Clinical Trial Grant
Awarded By
Ascentage Pharma Group
Start Date
October 25, 2019
End Date
June 5, 2025
Awarded By
Ascentage Pharma Group
Start Date
October 25, 2019
End Date
June 5, 2025